Publications

Borsky AE, Kroll-Desrosiers A, Rodriguez A, Fenwick K, Friedman JK, Yano EM. The State of VA-funded Women Veterans' Health Systems Research. Womens Health Issues. 2025[...]

By sjmartinez • March 30, 2025

Packard RRS, deKemp RA, Knuuti J, Moody JB, Renaud JM, Saraste A, Slomka PJ. Quantitative approaches to 18F-flurpiridaz positron emission tomography image analysis. J Nucl Cardiol.[...]

By sjmartinez • March 30, 2025

Yoo C, Ueno M, Klümpen HJ, Kelley RK, Vogel A, Furuse J, Ren Z, Yau T, Chan SL, Ozaka M, Oh SC, Gu S, Park[...]

By sjmartinez • March 30, 2025

Bransky NP, Kathuria-Prakash N, Sehl M. CRE25-032: Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CRE25-032. doi: 10.6004/jnccn.2024.7101. PMID: 40154331.

By sjmartinez • March 30, 2025

Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J[...]

By sjmartinez • March 30, 2025

Bardia A, Pistilli B, Rugo H. Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer. J Clin Oncol. 2025 Mar 28:JCO2402833.[...]

By sjmartinez • March 29, 2025

Jung SY, Pellegrini M, Yu H. Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African[...]

By sjmartinez • March 29, 2025

Kermani TA, Warrington KJ. Interleukin-6 inhibition for Takayasu's arteritis: before or after tumour necrosis factor inhibitors? Clin Exp Rheumatol. 2025 Mar 25. doi: 10.55563/clinexprheumatol/2acgxz. Epub[...]

By sjmartinez • March 29, 2025

Garcia-Manero G, Gaddh M, Platzbecker U, Lindsley RC, Larson SM, Chevassut T, Fenaux P, Komrokji R, Lyons R, Al-Kali A, Jiang Y, Bothos J, Townsley[...]

By sjmartinez • March 29, 2025

Jimenez J, Ni H, Katz SD, Haas GJ, Cao J, Rubens M, Chaparro S, Saxena A, Hofmeyer M, Kransdorf E, Ewald GA, Morris AA, Owens[...]

By sjmartinez • March 28, 2025